Broadway Financial (BYFC)
(Delayed Data from NSDQ)
$7.18 USD
-0.14 (-1.94%)
Updated Oct 18, 2024 03:04 PM ET
After-Market: $7.51 +0.34 (4.67%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Broadway Financial Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 53 | 37 | 28 | 19 | 18 |
Cost Of Goods | 8 | 2 | 2 | 3 | 4 |
Gross Profit | 45 | 35 | 26 | 16 | 14 |
Selling & Adminstrative & Depr. & Amort Expenses | 28 | 26 | 29 | 14 | 12 |
Income After Depreciation & Amortization | 17 | 9 | -3 | 1 | 2 |
Non-Operating Income | 0 | 0 | 0 | 0 | 0 |
Interest Expense | 10 | 1 | 2 | 2 | 2 |
Pretax Income | 7 | 8 | -5 | -1 | -1 |
Income Taxes | 2 | 2 | -1 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 5 | 6 | -4 | -1 | 0 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 5 | 6 | -4 | -1 | 0 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 17 | 9 | -2 | 2 | 2 |
Depreciation & Amortization (Cash Flow) | 0 | 0 | 1 | 1 | 1 |
Income After Depreciation & Amortization | 17 | 9 | -3 | 1 | 2 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 8.85 | 8.81 | 7.23 | 4.01 | 3.44 |
Diluted EPS Before Non-Recurring Items | 0.51 | 0.64 | -0.56 | -0.16 | -0.08 |
Diluted Net EPS (GAAP) | 0.51 | 0.64 | -0.56 | -0.16 | -0.08 |
Fiscal Year end for Broadway Financial Corporation falls in the month of December .
All items in Millions except EPS data.
9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | |
---|---|---|---|---|---|
Sales | NA | 15.76 | 15.10 | 16.96 | 12.26 |
Cost Of Goods | NA | 3.09 | 2.80 | 2.53 | 2.13 |
Gross Profit | NA | 12.68 | 12.30 | 14.43 | 10.13 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 7.77 | 8.07 | 7.84 | 6.98 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 4.91 | 4.23 | 6.59 | 3.15 |
Non-Operating Income | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | NA | 4.48 | 4.47 | 2.81 | 3.03 |
Pretax Income | NA | 0.42 | -0.24 | 3.79 | 0.13 |
Income Taxes | NA | 0.15 | -0.06 | 1.18 | 0.04 |
Minority Interest | NA | 0.00 | -0.02 | 0.00 | -0.01 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 0.27 | -0.18 | 2.61 | 0.09 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 0.27 | -0.16 | 2.61 | 0.09 |
Earnings Per Share Data | 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 8.97 | 8.41 | 8.41 | 8.83 |
Diluted EPS Before Non-Recurring Items | NA | 0.03 | -0.02 | 0.31 | 0.01 |
Diluted Net EPS (GAAP) | NA | 0.03 | -0.02 | 0.31 | 0.01 |